News & Insights

The California Department of Financial Protection and Innovation (“DFPI”) announced the suspension of implementation and enforcement of the Fair Investment Practices by Venture Capital Companies law (“FIPVCC”) pending new rulemaking

This update highlights key legislative and regulatory changes taking effect this winter, noteworthy lawsuits, and recent updates to Gunderson Dettmer’s Contract Generator, with links to deeper-dive resources where relevant

Gunderson Dettmer life sciences and public companies advisor Brett Pletcher was featured in Cure's article, "Technology Transfer in Biotech and Pharma and the Process of Scaling New Medicines," which explains how technology transfer works in biotech and pharma, the different types of transfers, and why poor execution can delay commercialization.

This session gives CFOs and GCs of late-stage private companies a practical, end-to-end IPO roadmap—from drafting the S-1 and structuring the offering to investor meetings, pricing, lockups, and the 2026 market outlook

This webinar equips GCs and CFOs of public companies with strategies to navigate shareholder communications, from annual meetings to investor engagement, with insights from Gunderson Dettmer’s Alexa Belonick and Brett Pletcher

This briefing helps founders, HR leaders, and in-house counsel prioritize what matters most for the year ahead

Sunday Robotics, the company building helpful home robots, announces its oversubscribed $165 million Series B financing, valuing the company at $1.15 billion

Hims & Hers, the leading health and wellness platform, announces its agreement to acquire Australian-based digital health leader, Eucalyptus, for up to $1.15 billion.

Gunderson Dettmer commemorates Black History Month in February 2026 with a series of events across its US offices, access to resources, and a tribute to this month’s theme, "A Century of Black History Commemorations."